Vivien Lee, MD

Professor

Neurology

Vivien Lee

Academic contact

333 W 10th Ave
Columbus, OH 43210-1239

Fax: 614-366-3447

Vivien.Lee@osumc.edu

Academic information

  • Department: Neurology

Research interests

  • Thrombolysis Related Complications in Acute Ischemic Stroke
  • Predictors of Outcomes After Subarachnoid Hemorrhage

About

Biography

My clinical research interests include thrombolysis related complications in acute ischemic stroke and predictors of outcome after subarachnoid hemorrhage.

Credentials

Education

Fellowship - Neurocritical Care
Mayo Clinic College of Medicine and Science, Rochester, MN, United States
7/2/2005 - 6/30/2006
Fellowship - Cerebrovascular & Skull Base
Mayo Clinic College of Medicine and Science, Rochester, MN, United States
6/24/2004 - 7/1/2005
Residency - Neurology
Cleveland Clinic Foundation, Cleveland, OH, United States
7/1/2001 - 6/30/2004
Internship - Internal Medicine
Cleveland Clinic Foundation, Cleveland, OH, United States
7/1/2000 - 6/30/2001
Doctor of Medicine (MD)
Pennsylvania State College of Medicine, Hershey, PA, United States
8/12/1996 - 5/21/2000

Certifications

  • American Heart Association National Center
    7/26/2021
  • American Board of Psychiatry & Neurology-Vascular Neurology
    6/19/2006
  • American Board of Psychiatry & Neurology-Neurology
    4/1/2005

Research

Research interests

  • Thrombolysis Related Complications in Acute Ischemic Stroke
  • Predictors of Outcomes After Subarachnoid Hemorrhage

Honors and Awards

  • 2016 American Academy of Neurology Fellow

Grants and Funding

  1. Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
    PI: Boehringer Ingelheim Study team
    Funding Source: Boehringer Ingelheim
    Annual Amount:
    Role: Site PI
    Dates: 7/2016-current
  2. Prospective Study on Intravenous Thrombolysis Related Coagulopathy in Acute Ischemic Stroke
    PI: Vivien Lee, MD
    Funding Source: Neurological Sciences Department Research Grant
    Annual amount: $20,000
    Role: PI
    Dates 11/2015-11/2016
  3. Insulin Resistance Intervention after Stroke (IRIS) trial
    PI: Walter Kernan, MD
    Funding source: NINDS (NS044876-03)
    Annual amount: $64,194
    Role: Local site Principal Investigator
    Dates: 7/2011 – 6/2016
  4. Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS 4)
    PI: DIAS 4 Study team
    Funding source: H. Lundbeck A/S (NCT00856661)
    Annual amount: $10,000
    Role: Local site Principal Investigator
    Dates: 6/2012 – 2014
  5. GORE HELEX Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients- The Gore REDUCE Clinical Study (HLX 06-03)
    PI: Scott E. Kasner, MD, FAHA
    Funding source: W.L.Gore & Associates (NCT00738894)
    Annual amount: $3000
    Role: Local site co- Principal Investigator
    Dates: 9/2008 – 6/2016
    RESPECT ESUS trial

More about my research